The company is in the process of being taken private by Sycamore Partners in a deal that is expected to close in the fourth quarter of this year.

Cencora, Inc. COR is well-poised for growth on the back of robust U.S. Healthcare Solutions business and product launches.

Walgreens Boots Alliance faces significant challenges, including declining margins, rising labor costs, and fierce ...

Adjusted earnings came in at $0.63 per share for the three-month period ended Feb. 28, exceeding analyst expectations of ...

Walgreens Boots Alliance reported stronger-than-expected second-quarter earnings Tuesday as the pharmacy chain accelerated ...

Over the past 12 months, Cencora brought back 9.68% to its investors. On February 6, the company confirmed it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance ...

Alto and Cencora are collaborating to deliver enhanced patient support services and streamline access to prescribed specialty medications. The collaboration leverages Cencora’s patient support ...